Chr. Hansen and Novozymes write history as Denmark’s largest merger, scaling up production
date:Dec 20, 2022
Enzymes manufacturer Novozymes has agreed to buy Chr. Hansen to expand in the nutrition industry. The merger resulted in a US$12.3 billion deal, writing history as the largest Danish merger on record and will close by the end of 2023.

The combined group will have increased scale and efficiency and more capabilities to unlock significant growth opportunities by translating needs into transformational solutions for our customers and consumers, Anders Lund, executive vice president for Consumer B
1/12 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
04/20 22:25